Supplementary Table S3 from Impact of RNA Signatures on pCR and Survival after 12-Week Neoadjuvant Pertuzumab plus Trastuzumab with or without Paclitaxel in the WSG-ADAPT HER2+/HR− Trial
Authors:
- Monika GraeserMGMonika Graeser
- Oleg GluzOGOleg Gluz
- Claudia BiehlCBClaudia Biehl
- Daniel Ulbrich-GebauerDUDaniel Ulbrich-Gebauer
- Matthias ChristgenMCMatthias Christgen
- Jenci PalattyJPJenci Palatty
- Sherko KuemmelSKSherko Kuemmel
- Eva-Maria GrischkeEGEva-Maria Grischke
- Doris AugustinDADoris Augustin
- Michael BraunMBMichael Braun
- Jochem PotenbergJPJochem Potenberg
- Rachel WuerstleinRWRachel Wuerstlein
Open Access
- 25 November 2025
- other
- Published by American Association for Cancer Research (AACR)